A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Recruiting · NCT06823167 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of IM-1021 in Participants With Advanced Cancer | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2026-08-10 | NCT06823167 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immunome, Inc. | 5 |
24 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.